Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion type Assertion NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_head.
- NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion description "[The ovarian cancer cell lines OvCa3 and A2780 were further used to test the hypothesis that CRH might contribute to the immune privilege of ovarian tumours, by modulating FasL expression on the cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_provenance.
- NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion evidence source_evidence_literature NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_provenance.
- NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion SIO_000772 17667919 NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_provenance.
- NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion wasDerivedFrom befree-20150227 NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_provenance.
- NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_assertion wasGeneratedBy ECO_0000203 NP326148.RAKoJzml0JFjJRDrJeoeTR8VFu7-d2MkofBWGEKT-ba-4130_provenance.